Lipo Removes Fat But Not Type 2
Researchers at Washington State University School of Medicine in St. Louis, Missouri, write that abdominal liposuction “. . . does not significantly improve obesity-associated metabolic abnormalities.”
The effect of abdominal liposuction on risk factors for coronary heart disease in women with abdominal obesity was observed in 15 obese women before and 10 to 12 weeks after liposuction. Eight of the women had normal glucose tolerance and seven had type 2 diabetes.
Liposuction decreased abdominal fat by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes. However, liposuction did not significantly alter the insulin sensitivity of muscle, liver or adipose tissue; did not significantly alter inflammation markers; and did not significantly affect blood pressure, plasma glucose, insulin, and lipid concentrations in either group.
— New England Journal of MedicineClick Here To View Or Post Comments